Latent variable modeling and its implications for institutional review board review: variables that delay the reviewing process

Institutional Review Board Barriers and Solutions Encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now Study: A National Multicenter Practice-Based Implementation Trial

(2013) Eric J. MacLaughlin et al.   PHARMACOTHERAPY

Genetics researchers’ and IRB professionals’ attitudes toward genetic research review: a comparative analysis

(2012) Karen L. Edwards et al.   GENETICS IN MEDICINE

Individual genetic and genomic research results and the tradition of informed consent: exploring US review board guidance

(2012) Christian Simon et al.   JOURNAL OF MEDICAL ETHICS

A Systematic Review of the Empirical Literature Evaluating IRBs: What We Know and What We Still Need to Learn

(2011) Lura Abbott et al.   Journal of Empirical Research on Human Research Ethics

Burdens on Research Imposed by Institutional Review Boards: The State of the Evidence and Its Implications for Regulatory Reform

(2011) GEORGE SILBERMAN et al.   MILBANK QUARTERLY

Ethical issues posed by cluster randomized trials in health research

(2011) Charles Weijer et al.   Trials

Quality of Reporting of Serious Adverse Drug Events to an Institutional Review Board: A Case Study with the Novel Cancer Agent, Imatinib Mesylate

(2009) D. A. Dorr et al.   CLINICAL CANCER RESEARCH

Density of cerebellar basket and stellate cells in autism: Evidence for a late developmental loss of Purkinje cells

(2009) Elizabeth R. Whitney et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Pacemaker Therapy for Early and Late Sinus Node Dysfunction in Orthotopic Heart Transplant Recipients: A Single-Center Experience

(2008) JEFFREY J. LUEBBERT et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY